147 related articles for article (PubMed ID: 15766573)
1. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola.
Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J
Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573
[TBL] [Abstract][Full Text] [Related]
2. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
Maffucci T; Piccolo E; Cumashi A; Iezzi M; Riley AM; Saiardi A; Godage HY; Rossi C; Broggini M; Iacobelli S; Potter BV; Innocenti P; Falasca M
Cancer Res; 2005 Sep; 65(18):8339-49. PubMed ID: 16166311
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
7. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
[TBL] [Abstract][Full Text] [Related]
8. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis.
Tong Y; Zhang X; Zhao W; Zhang Y; Lang J; Shi Y; Tan W; Li M; Zhang Y; Tong L; Lu H; Lin L; Ding J
Eur J Pharmacol; 2004 Jun; 494(2-3):101-9. PubMed ID: 15212963
[TBL] [Abstract][Full Text] [Related]
10. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
[TBL] [Abstract][Full Text] [Related]
11. Suppression of angiogenesis by the plant alkaloid, sanguinarine.
Eun JP; Koh GY
Biochem Biophys Res Commun; 2004 Apr; 317(2):618-24. PubMed ID: 15063803
[TBL] [Abstract][Full Text] [Related]
12. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
13. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
14. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
15. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
